U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354178) titled 'Study of Collagen-Based Thrombin Hemostat for the Control of Bleeding in Spinal Surgery' on Nov. 24, 2025.
Brief Summary: This clinical trial evaluates the effectiveness and safety of a collagen-based hemostatic agent containing thrombin in patients undergoing spinal surgery. The study compares this investigational product with an existing hemostatic agent to assess whether it performs equally well in controlling surgical bleeding. Patients with spinal stenosis, tumors, or trauma who require spinal surgery will be enrolled. The hemostat will be applied intraoperatively when grade 3 bleeding is observed. The study aims to determine h...